Clinical trial

Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography

NCT06022068

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-09-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2023-09-01Date precision: day

Registry last updated2025-07-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

SirolimusDRUG · verified · RxNorm: sirolimus

Sponsors & collaborators

Karolinska Institutetlead sponsor

Karolinska University Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06022068 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.